Glucotrack, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Glucotrack, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was -$50.00K.
- Glucotrack, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $4.32M, a 764.00% increase year-over-year.
- Glucotrack, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $6.39M.
- Glucotrack, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $0.00.
- Glucotrack, Inc. stock issued during period, value, new issues for fiscal 2025 was $10.66M.
- Glucotrack, Inc. stock issued during period, value, new issues for fiscal 2023 was $8.73M.
- Glucotrack, Inc. stock issued during period, value, new issues for fiscal 2020 was $12.25M.
- Glucotrack, Inc. stock issued during period, value, new issues for fiscal 2018 was $2.50M, a 1313.82% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $10.66M 10-K · filed 2026-03-30 |
| 2025-06-30 | $4.32M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.39M 10-Q · filed 2026-05-14 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2024-06-30 | $500.00K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $8.73M 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-06-30 | $8.73M 10-Q · filed 2024-08-13 | |
| 2020-12-31 | -$182.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $12.25M 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2020-06-30 | $182.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | |
| 2020-03-31 | $12.25M 10-Q · filed 2021-05-21 | |
| 2019-06-30 | $3.21M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $704.24K 10-Q · filed 2020-05-19 | |
| 2018-12-31 | $2.50M 10-K · filed 2020-04-14 | |
| 2018-06-30 | $364.75K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $856.01K 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $177.06K 10-K · filed 2019-04-15 | |
| 2012-12-31 | $917.18K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |